Browsing by Author Wang, Jin-Wan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 7 of 7
Issue Date Title Author(s)
2013 The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries Sun, Guo-ping;Sun, Yan;Xu, Rui-hua;Xu, Jian-Ming;Li, Jin;Wang, Jin-Wan;Qin, Shukui;Feng, Ji Feng;Ba, Yi;Shen, Lin;Bai, Yu-Xian;Sun, Yihong;Pan, Hongming;Cheng, Ying;Yu, Shiying;Zhong, Haijun;Bai, Li;Luo, Rongcheng;Kobayashi, Mikiro;Ohtsu, Atsushi
2013 Comparison of PFS and safety for Asian compared to North American and European populations in the phase III trial of pazopanib versus sunitinib in patients with treatment-naive RCC (COMPARZ) Guo, Jun;Jin, Jie;Huang, Yiran;Wang, Jin-Wan;Lim, Ho Yeong;Uemura, Hirotsugu;Rha, Sun Young;Wu, Hsi Chin;Crescenzo, Rocco;Deen, Keith C.;McCann, Lauren;Motzer, Robert John
2018 Efficacy and safety of first-line sunitinib in Chinese patients with metastatic renal cell carcinoma Qin, Shu-Kui;Jin, Jie;Guo, Jun;Wang, Jin-Wan;Zhou, Fang-Dian;Huang, Yi-Ran;Ren, Xiu-Bao;Ye, Ding-Wei;Pan, Sharon;Sajben, Peter;Wang, Qiao
2017 Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial Xu, Rui-Hua;Shen, Lin;Wang, Ke-Ming;Wu, Gang;Shi, Chun-Mei;Ding, Ke-Feng;Lin, Li-Zhu;Wang, Jin-Wan;Xiong, Jian-Ping;Wu, Chang-Ping;Li, Jin;Liu, Yun-Peng;Wang, Dong;Ba, Yi;Feng, Jue-Ping;Bai, Yu-Xian;Bi, Jing-Wang;Ma, Li-Wen;Lei, Jian;Yang, Qing;Yu, Hao
2013 Hand-foot syndrome (HFS) and asthenia/fatigue (A/F) as biomarkers of sunitinib efficacy in Chinese patients (pts) with metastatic renal cell carcinoma (mRCC). Qin, Shukui;Jin, Jie;Guo, Jun;Wang, Jin-Wan;Zhou, Fang-Jian;Huang, Yi-Ran;Ren, Xiu-Bao;Ye, Ding-Wei;Pan, Sharon;Sajben, Peter;Wang, Qiao
2013 Hypertension and myelosuppression as biomarkers of sunitinib efficacy in Chinese patients (pts) with metastatic renal cell carcinoma (mRCC) Qin, Shukui;Jin, Jie;Guo, Jun;Wang, Jin-Wan;Zhou, Fang-Jian;Huang, Yi-Ran;Ren, Xiu-Bao;Ye, Ding-Wei;Pan, Sharon;Sajben, Peter;Wang, Qiao
2012 UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil Wang, Yan;Shen, Lin;Xu, Nong;Wang, Jin-Wan;Jiao, Shun-Chang;Liu, Ze-Yuan;Xu, Jian-Ming